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The rising incidence of hepato-cellular carcinoma (HCC), com-
bined with a decrease of available liver grafts, especially in wes-
tern countries, have led to reﬁned selection criteria for liver
transplantation (LT) candidates. Hence, prognostic criteria of
HCC include not only size and number of tumor nodules, but also
the presence of micro- and macro-vascular invasions, satellite
nodules, and differentiation grade [1]. Non-invasive diagnostic
imaging has gained wide acceptance for the diagnosis of HCC in
liver cirrhosis, even when dealing with less than 2 cm large nod-
ules [2]. Recent instrumental developments in imaging ﬁelds
open new horizons for non-invasive tissue and cellular character-
ization of liver tumors.
SpeciﬁcMRI featuresofHCCnodulesareknowntobeassociated
with good differentiation: the presence of liver nodules with high
signal intensity (SI) on T1 Weighted Imaging (WI) and signal
drop-out on out-of-phase T1WI has been reported to be associated
with good differentiation (Fig. 1) [3]. More recently, Asayama et al.
have studied the sequential changes of HCC arterial blood over
time: 60 HCC nodules were included and separated in four groups,
based on their enhancement proﬁles on Computed Tomography
Hepatic Arteriography (CTHA) and CT during arterioportography
(CTAP). Signiﬁcantly different hemodynamic patterns were pres-Journal of Hepatology 20
Received 18 January 2011; received in revised form 22 January 2011; accepted 25
January 2011
⇑ Corresponding author. Address: AP-HP, Groupe Henri Mondor Albert Chenevier,
Imagerie Médicale, CHU Henri Mondor, 51 Avenue du Marechal de Lattre de
Tassigny, 94010 Creteil Cedex, France. Tel.: +33 1 49 81 46 31; fax: +33 1 49 81 26
32.
E-mail address: alain.luciani@hmn.aphp.fr (A. Luciani).was predominantly documented in moderately differentiated
HCC, but was less frequently encountered in both well-differenti-
ated and highly poorly differentiatedHCC. The recent study by Iav-
arone et al. published in Hepatology. 2010;52(5):1723–1730,
further highlights the variability of dynamic enhancement pattern
of HCC nodules in respect to cell differentiation : 62 HCC were
consecutively detected by imaging using Contrast Enhanced
Ultra-Sound and/or CT and/or MRI, and thereafter systematically
conﬁrmedbyﬁneneedle biopsy. The enhancement proﬁle of Grade
I tumors (Edmondson-Steiner) was signiﬁcantly different from
that of grades II and III tumors, whatever tumor size considered,
although differences were most pronounced when dealing with
1–2 cm large tumors. Only 19 out of 47 nodules ranging from 1
to 2 cm were correctly diagnosed as HCC according to typical
enhancement proﬁles, as opposed to 10 out of 12 nodules larger
than 2 cm. Moreover, only 13% of grade I tumors ranging from 1
to 2 cm were correctly classiﬁed as opposed to 55% of Grades
II–III tumors of the same size. Results of this study raise important
questions regarding non-invasive diagnostic imaging:
 AASLD or EASL criteria mostly rely on enhancement proﬁles
of tumor nodules; however, since enhancement proﬁles
vary with tumor grade, it cannot be excluded that the sen-
sitivity and speciﬁcity of non-invasive diagnostic criteria for
HCC in cirrhotic liver may be decreased when dealing with
well-differentiated tumors. Interestingly, the reported rates
of missed tumors on explanted livers in patients undergoing
LT for HCC do not exceed 10% [5]. These tumors over-looked
by absence of pathognomonic dynamic enhancement pat-
tern (AASLD criteria) could therefore be more frequently
well-differentiated, with potentially less impact on the
recurrence rate after LT. As a result, the study by Lavarone
et al. does not question the use of AASLD criteria for HCC
characterization in cirrhotic livers.
 Deﬁning tumor grade on Fine Needle Biopsy still appears
challenging as opposed to tumor resection. Since imaging
provides an assessment of the entire tumor, novel imaging
technologies could indeed become novel tools allowing an
overall tumor tissue characterization approach.11 vol. 55 j 224–226
Fig. 1. Fifty-seven-year old patient with liver cirrhosis and right lobe hepatocellular carcinoma referred for liver MRI. Transverse gradient echo (GE) in-phase T1WI (TR/
TE/a; 119 ms/4.8 ms/70; slice thickness 5 mm) shows a 4 cm peripherally located liver tumor, with high signal intensity (Arrow, A) and drop of signal intensity on out-of-
phase T1WI (TR/TE/a; 119 ms/2.4 ms/70; slice thickness 5 mm) (Arrow, B) suggesting the presence of fat within the tumor. The tumor is iso-intense on Transverse Turbo
Spin Echo (TSE) T2WI (TR/TE/a; 2410 ms/82 ms/150; slice thickness 5 mm) (C), with absent visible restriction on ADCmapping (DiffusionWeighted Imaging, Arrow, D). The
tumor displays mild arterial enhancement on transverse 3D VIBE (Volumetric Interpolated Breath-hold Examination) T1WI (TR/TE/a; 3.17/1.33/20; slice thickness 3 mm) (E)
with washout on delayed enhancement phase (Arrow, F). A well-differentiated HCC nodule was conﬁrmed on pathology following liver transplantation (Arrow, G).
JOURNAL OF HEPATOLOGY If enhancement proﬁles are inﬂuenced by cell-differentia-
tion, there is a clear need for additional imaging tools in
order to optimize the accuracy of non-invasive diagnostic
procedures. Diffusion MRI (DWI) allows the characteriza-
tion of microscopic proton displacement, and has pro-
foundly improved oncologic imaging [6]. Owing to
respiratory triggering and parallel acquisition techniques,
DWI can be applied to liver imaging, improving both liverJournal of Hepatology 201cirrhosis characterization and tumor detection [7]. More
recently, Nasu et al. have assessed whether tumor SI on
DWI could match histopathologic tumor grade [8]: 125
resected HCC specimens were retrospectively reviewed
and DWI ﬁndings correlated to pathological data; although,
DWI signal intensity of HCC nodules increased with tumor
grade, no correlation could be demonstrated between
tumor grade and Apparent Diffusion Coefﬁcient (ADC). The1 vol. 55 j 224–226 225
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use of Positon Emission Tomography with 18F Deoxy Glu-
cose (FDG-PET) for the detection of HCC has been over-
looked for many years because of its limited sensitivity. In
2009, Lee et al. reported in a series of 59 patients trans-
planted for HCC that FDG-PET was an independent prognos-
tic factor for tumor recurrence and probability of survival,
along with the presence of vascular invasion [9]. Hence,
functional tumor imaging could provide additional informa-
tion regarding patient prognosis.
Owing to instrumental innovations, increased spatial resolu-
tion, improved respiratory triggering and post-treatment algo-
rithms, imaging techniques now combine morphological and
functional analysis; enhancement proﬁles more narrowly match
pathological angiogenetic patterns, and as shown by Lavarone
et al., it can provide insight regarding tumor differentiation.
DWI and PET-CT are alternative functional tools which in turn
will provide additional information on tissue differentiation.
Twenty ﬁrst century imaging could well move on from ‘‘organ
imaging’’ to the era of tissue or cellular imaging.Conﬂict of interest
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